[HTML][HTML] Applications of artificial intelligence for patients with peripheral artery disease

F Lareyre, CA Behrendt, A Chaudhuri, R Lee… - Journal of vascular …, 2023 - Elsevier
Objective Applications of artificial intelligence (AI) have been reported in several
cardiovascular diseases but its interest in patients with peripheral artery disease (PAD) has …

[HTML][HTML] Differences in symptom presentation in women and men with confirmed lower limb peripheral artery disease: a systematic review and meta-analysis

CP Porras, ML Bots, M Teraa, S van Doorn… - European Journal of …, 2022 - Elsevier
Objective To evaluate the differences in symptoms between men and women that present
with lower limb peripheral artery disease (PAD). Data Sources Systematic review and meta …

[HTML][HTML] Editor's choice--European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral …

J Nordanstig, CA Behrendt, I Baumgartner… - European Journal of …, 2024 - Elsevier
BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …

[HTML][HTML] Editor's Choice–International variations and sex disparities in the treatment of peripheral arterial occlusive disease: a report from VASCUNET and the …

CA Behrendt, B Sigvant, J Kuchenbecker… - European Journal of …, 2020 - Elsevier
Objective The aim of this study was to determine sex specific differences in the invasive
treatment of symptomatic peripheral arterial occlusive disease (PAOD) between member …

Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project

M Hadwiger, N Dagres, J Haug, M Wolf… - European heart …, 2022 - academic.oup.com
Aims Cardiac resynchronization therapy (CRT) is an established treatment for heart failure.
There is contradictory evidence whether defibrillator capability improves prognosis in …

[HTML][HTML] Editor's Choice–The GermanVasc score: a pragmatic risk score predicts five year amputation free survival in patients with peripheral arterial occlusive disease

T Kreutzburg, F Peters, J Kuchenbecker… - European Journal of …, 2021 - Elsevier
Objective Patients with peripheral arterial occlusive disease (PAOD) face an increased risk
of both lower limb amputation and death. To date, it has been challenging to predict the long …

Long‐Term Effectiveness and Safety of Initiating Statin Therapy After Index Revascularization In Patients With Peripheral Arterial Occlusive Disease

F Peters, J Kuchenbecker, T Kreutzburg… - Journal of the …, 2020 - Am Heart Assoc
Background An increasing number of patients with a peripheral arterial occlusive disease
were put on statins during the past years. This study assessed whether statin therapy was …

Distribution of mobile health applications amongst patients with symptomatic peripheral arterial disease in Germany: a cross-sectional survey study

K Alushi, I Hinterseher, F Peters, U Rother… - Journal of Clinical …, 2022 - mdpi.com
Background: Broadly available digital and mobile health applications (also known as
mHealth) have recently gained increasing attention by the vascular community, but very little …

A prospective survey study on the education and awareness about walking exercise amongst inpatients with symptomatic peripheral arterial disease in Germany

Y Li, U Rother, Y Rosenberg, I Hinterseher, C Uhl… - Vasa, 2023 - econtent.hogrefe.com
Background: To determine the adherence to supervised exercise training and underlying
reasons for non-adherence amongst patients with inpatient treatment of symptomatic lower …

[HTML][HTML] Editor's Choice–European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on antithrombotic therapy for vascular diseases

CP Twine, SK Kakkos, V Aboyans… - European Journal of …, 2023 - Elsevier
1.1. Purpose The European Society for Vascular Surgery (ESVS) has developed a series of
clinical practice guidelines for clinicians caring for patients with vascular diseases. This is …